All sponsors

Sanofi Pasteur, a Sanofi Company $SNY

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS9
PHASE 3 / 2-33
RECRUITING2
READOUTS ≤12 MONTHS4
READOUT SLIPPED >6 MO44%

Delay Index: of 9 active trials registered more than a year ago, 4 have moved their primary completion (readout) date by more than 6 months since first registration (median +4.4 months). See all sponsors →

Open Sanofi Pasteur, a Sanofi Company on the live radar map → 📅 $SNY readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Yellow fever vaccine (produced on serum-free Vero cells)
NCT05011123
P2Active, not recruitingYellow Fever6902022-05-23 (+4 mo)
VYF02
NCT04942210
P2Active, not recruitingYellow Fever; Healthy Volunteers5682022-06-24 (+7 mo)
Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine
NCT04936685
P3Active, not recruitingMeningococcal Immunisation; Healthy Volunteers2092023-03-09 (+4 mo)
PCV21
NCT06838000
P3Active, not recruitingPneumococcal Infections12682026-12-01 (+6 mo)
Investigational hMPV/RSV vaccine
NCT06686654
P1/2Active, not recruitingHuman Metapneumovirus Immunization; Respiratory Syncytial Virus Immunization15302027-01-18 (-6 mo)
Pentavalent Meningococcal ABCYW vaccine
NCT06647407
P1/2Active, not recruitingMeningococcal Immunization; Healthy Volunteers7502027-05-17
PCV21 vaccine
NCT06736041
P3Active, not recruitingPneumococcal Immunization17142027-05-17
Acne mRNA vaccine
NCT06316297
P1/2RecruitingAcne8002028-11-30 (+11 mo)
Acne mRNA vaccine
NCT07013747
P1/2RecruitingAcne2282029-06-19 (+33 mo)